-
-
-
-
-
-
-
Crown Laboratories Completes Acquisition of Revance Therapeutics
-
-
-
-
-
-
-
Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)
-
-
-
-
-
-
-
Revance Therapeutics (RVNC) Misses Q3 EPS by 10c
-
-
-
-
-
-
-
Revance Therapeutics (RVNC) Halted, News Pending
-
408,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

